 |
| JUly
8, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras |
| In
this Q&A, Suh discusses what drew him
to Inocras, why whole-genome analysis is
approaching an inflection point, how
Inocras is building the evidence base for
broader clinical adoption, and what it
will take for whole-genome-based care to
become the new standard in oncology and
rare disease. More
|
|
|
 |
|
One Partner For Your Entire
Vivarium. Research Ready From Day
One. |
|
Learn More
→ |
|
|
- Agilent: Expands Altura Portfolio With Inert
Size Exclusion and PLRP-S Columns for
Biotherapeutic Analysis More
- Bifrost Biosystems: Pens Agreement With
Illumina for Supply of Sequencing Chemistry
for Optical Pooled Screening Platform More
- Helix: Multi-Year Agreement With
AstraZeneca to Support Genomic Research for
Drug Discovery and Development More
More*
- Octave: New Independent Study Establishes
the MSDA Test as an Objective Measure to
Distinguish True MS Relapse from
Pseudoexacerbation More
- Penumbra: First Patient Enrolled in FORWARD
Study Evaluating Mechanical Thrombectomy and
Computer Assisted Vacuum Thrombectomy for
Distal Acute Ischemic Stroke More
- Revolution Medicines: European Medicines
Agency Expedites Assessment of Daraxonrasib
Under Phased Review Process More
- RoosterBio and Applied StemCell: Partner to
Advance Scalable iPSC-Based Bioprocess
Solutions More
- Seer: Board of Directors Issues Letter to
Shareholders Demonstrating the Strength and
Experience of Seer’s Director Nominees More
- Shape Memory Medical: Completes Enrollment
in Landmark AAA‑SHAPE Randomized Controlled
Pivotal Trial More
- Vera Therapeutics: Receives FDA
Accelerated Approval for TRUTAKNA for Adult
Patients With Primary IgA Nephropathy More
More
More*
More*
|
|
 |
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- BioPharmCatalyst Weekly Watchlist: Key PDUFA
and Regulatory Catalysts for the Next 6 Months
More
- InMed Pharmaceuticals and Mentari
Therapeutics: Amendment to Merger Agreement
and Filing of Registration Statement on Form
S-4
More
- Pacira BioSciences: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Young Biotech Faces ‘Best Test’ in Cancer
Fight With $130M in Funding More*
|
|
 |
| Biotech’s
most flexible vivarium lab space
to launch and scale studies. |
|
Learn More
→ |
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026 More
- Big4Bio CEO Weekly Q&A: Jehee
Suh, CEO, Inocras More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Quest for Large-Scale DNA More
|
|
- ICYMI: A View From the Trenches - Biotech
Series A in 2026 More
- ICYMI: CapsoVision Appoints Gastroenterology
Leader David S. Shields, M.D., to Board of
Directors More
- ICYMI:
Genentech to Lay Off Veteran Scientists as
Part of More Than 100 Job Cuts for Biotech
Pioneer More*
More
More
- OPPORTUNITY: Chief Executive Officer,
Cambridge, MA
More
- OPPORTUNITY: Chief Financial Officer, Pine
Brook, NJ / Hybrid
More
- OPPORTUNITY: Vice President, Global BD,
Remote
More
- Slone Partners: How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare
More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
